Seoulin Bioscience Co.Ltd (038070) — Cash Flow Reinvestment Rate
Seoulin Bioscience Co.Ltd (038070) has a Cash Flow Reinvestment Rate of 3.24x as of December 2025, reinvesting ₩2.05 Billion (capex ₩10.90 Million plus investments ₩-2.04 Billion) from operating cash flow of ₩631.76 Million. Explore capital reinvestment ratio of Seoulin Bioscience Co.Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Seoulin Bioscience Co.Ltd Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Seoulin Bioscience Co.Ltd across 11 annual periods. Also explore 038070 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Seoulin Bioscience Co.Ltd (2013–2025)
Year-by-year capital reinvestment analysis for Seoulin Bioscience Co.Ltd. For live market cap and broader valuation context, see Seoulin Bioscience Co.Ltd (038070) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.53x | ₩16.79 Billion | ₩4.76 Billion | ₩507.47 Million | ▼ -88.5% |
| 2023 | 30.63x | ₩28.50 Billion | ₩930.57 Million | ₩974.21 Million | ▲ +723.4% |
| 2021 | 3.72x | ₩33.17 Billion | ₩8.92 Billion | ₩1.67 Billion | ▲ +582.2% |
| 2020 | 0.55x | ₩2.01 Billion | ₩3.68 Billion | ₩401.34 Million | ▲ +60.2% |
| 2019 | 0.34x | ₩2.49 Billion | ₩7.32 Billion | ₩269.29 Million | ▼ -22.9% |
| 2018 | 0.44x | ₩1.84 Billion | ₩4.17 Billion | ₩408.02 Million | ▼ -95.6% |
| 2017 | 10.01x | ₩13.03 Billion | ₩1.30 Billion | ₩8.73 Billion | ▲ +84.0% |
| 2016 | 5.44x | ₩15.00 Billion | ₩2.76 Billion | ₩7.21 Billion | ▲ +401.9% |
| 2015 | 1.08x | ₩4.46 Billion | ₩4.12 Billion | ₩3.74 Billion | ▲ +195.0% |
| 2014 | 0.37x | ₩1.01 Billion | ₩2.74 Billion | ₩761.57 Million | ▲ +3162.2% |
| 2013 | 0.01x | ₩55.65 Million | ₩4.94 Billion | ₩55.65 Million | — |